David Avigan, MD

David Avigan, MD

Director, Hematologic Malignancies/Bone Marrow Transplant at Beth Israel Deaconess Medical Center Harvard Medical Faculty Physicians (HMFP) at Beth Israel Deaconess Medical Center

Research Focus:
My research interest lies in the field of tumor immunotherapy and its incorporation into bone marrow transplantation. Active projects include the development of dendritic cell tumor fusions to be used as tumor vaccines in clinical trials for multiple myeloma and solid tumor patients. I have also been exploring the number of immune reconstitution post-transplant and studying the impact of cytokine therapy with IL-12 and GM-CSF on this process. I am currently leading a new trial in the use of post-transplant Her2Neu antibody therapy assessing its impact on persistent residual disease. One group is investigating novel approaches to allogeneic transplantation including the use of non-myeloablative approaches.

Additional Resources

years treating myeloma: 33

Number of Myeloma Patients Treated Annually:

Details & contact info

Beth Israel Deaconess Medical Center

330 Brookline Avenue Fenway
Boston, MA, United States, 2215

Phone: 617-667-7000

View Full Physician Bio

View Website

Send a message to David Avigan, MD


Thanks to our Myeloma Crowd Community sponsors:

.                         .       .